Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8801
PUT
Ultragenyx Pharmaceutical
RARE
$2.61B
| $377K | ﹤0.01% |
9,400
-7,800
| -45% | -$335K |
|
8802
Tompkins Financial
TMP
$1.46B
| $377K | ﹤0.01% |
5,692
-16,044
| -74% | -$1.18M |
|
|
CTLP
8803
PUT
DELISTED
Cantaloupe
CTLP
| $377K | ﹤0.01% |
66,100
+45,700
| +224% | +$243K |
|
8804
Superior Group of Companies
SGC
$208M
| $377K | ﹤0.01% |
47,871
+20,440
| +75% | +$220K |
|
8805
CALL
Sundial Growers
SNDL
$313M
| $377K | ﹤0.01% |
235,450
-324,300
| -58% | -$636K |
|
8806
PUT
iShares Russell 3000 ETF
IWV
$20.5B
| $377K | ﹤0.01% |
1,600
-700
| -30% | -$162K |
|
8807
SiriusPoint
SPNT
$2.76B
| $376K | ﹤0.01% |
46,299
+18,311
| +65% | +$129K |
|
8808
CALL
Old National Bancorp
ONB
$10.4B
| $376K | ﹤0.01% |
26,100
+18,600
| +248% | +$315K |
|
|
CTO
8809
PUT
CTO Realty Growth
CTO
$825M
| $376K | ﹤0.01% |
21,800
+7,500
| +52% | +$136K |
|
8810
RBB Bancorp
RBB
$467M
| $376K | ﹤0.01% |
24,271
-28,166
| -54% | -$539K |
|
8811
CALL
VanEck Steel ETF
SLX
$173M
| $376K | ﹤0.01% |
5,900
-500
| -8% | -$32.3K |
|
8812
CALL
FormFactor
FORM
$10.3B
| $376K | ﹤0.01% |
11,800
+300
| +3% | +$8.6K |
|
8813
CALL
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.85B
| $376K | ﹤0.01% |
8,800
+8,100
| +1,157% | +$345K |
|
8814
Avantis Short-Term Fixed Income ETF
AVSF
$654M
| $376K | ﹤0.01% |
+8,106
| New | +$374K |
|
8815
CALL
SELLAS Life Sciences
SLS
$2.58B
| $376K | ﹤0.01% |
262,600
-67,800
| -21% | -$168K |
|
|
ITI
8816
DELISTED
Iteris, Inc.
ITI
| $375K | ﹤0.01% |
+80,062
| New | +$335K |
|
|
ACH
8817
CALL
Accendra Health
ACH
$73.1M
| $375K | ﹤0.01% |
25,800
-42,100
| -62% | -$754K |
|
8818
CALL
Upland Software
UPLD
$15.7M
| $375K | ﹤0.01% |
8,730
+690
| +9% | +$47.8K |
|
8819
CALL
Seres Therapeutics
MCRB
$45.6M
| $375K | ﹤0.01% |
3,310
+275
| +9% | +$29.7K |
|
|
NAPA
8820
CALL
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $375K | ﹤0.01% |
23,600
+700
| +3% | +$11K |
|
8821
PUT
Playboy Inc
PLBY
$151M
| $375K | ﹤0.01% |
189,500
+40,500
| +27% | +$101K |
|
8822
United States Lime & Minerals
USLM
$3.37B
| $375K | ﹤0.01% |
+12,285
| New | +$374K |
|
8823
IDEX
IEX
$17.6B
| $375K | ﹤0.01% |
1,623
-772
| -32% | -$175K |
|
8824
Caesarstone
CSTE
$119M
| $375K | ﹤0.01% |
90,762
+33,050
| +57% | +$183K |
|
|
FBZ
8825
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $375K | ﹤0.01% |
38,742
+4,027
| +12% | +$42.2K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,466 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.